Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Speciality Medicines IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Speciality Medicines Limited IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE & RoNW
The Company Key Performance Indicates the pre-issue EPS of ₹
14.1 and post-issue EPS of ₹
9.80 for FY25. The pre-issue P/E ratio is
8.79x,while the post-issue P/E ratio is
Key Performance Indicator
| KPI | Values |
|---|---|
| EPS Pre IPO (Rs.) | 14.1 |
| EPS Post IPO (Rs.) | 9.80 |
| Adjusted 12M EPS Post IPO (Rs.) | 11.82 |
| P/E Pre IPO | 8.79 |
| P/E Post IPO | 12.66 |
| Adjusted 12M P/E Post IPO | 10.49 |
| ROE | 37.85% |
| ROCE | 33.39% |
| P/BV | 2.62 |
| Debt/Equity | 0.17 |
| RoNW | 28.30% |
| EBITDA Margin | 15.60% |
| PAT Margin | 14.70% |
© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com
